Astrazeneca AZN
NYSE AZN
$156.91 -0.77 (-0.49%)
At close: Oct 2, 2026 · 4:00 PM EDT

Astrazeneca (AZN) Net Equity Issued and Repurchased (2009 - 2026)

Updated

Astrazeneca (AZN) recorded Net Equity Issued and Repurchased of $6 million in Q2 2026, up 50.0% from $4 million a year earlier but down 40.0% from the prior quarter.

Analysis

Astrazeneca (AZN) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends

On a TTM basis, Astrazeneca's Net Equity Issued and Repurchased came in at $44 million as of Jun 30, 2026, up 12.8% year-over-year; for FY2025, it came in at $40 million, up 5.3% from FY2024.

  • Annual Net Equity Issued and Repurchased has increased for three straight years, with a five-year compound annual growth rate of 5.9% (FY2020 to FY2025).
  • Across earlier years, Net Equity Issued and Repurchased came in at $38 million in FY2024 (+15.2%), $33 million in FY2023 (+13.8%), $29 million in FY2022 (unchanged) and $29 million in FY2021 (-3.3%).
  • Quarterly Net Equity Issued and Repurchased has ranged from $1 million in Q3 2021 to $23 million in Q4 2025 over the past five years.
  • On a year-over-year basis, Net Equity Issued and Repurchased rose in four of the last six quarters, with growth averaging 18.9%.
  • Peak year-over-year performance for Net Equity Issued and Repurchased in the last five years was growth of 50.0% in Q2 2026, against a decline of 50.0% in Q3 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $10 million (Q1 2026), $23 million (Q4 2025) and $5 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 6.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 9.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Vertex Pharmaceuticals 127.87 Bn 99.88 Bn 2.84 Bn 47.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.00 Mn
Mar 31, 2026 10.00 Mn
Dec 31, 2025 23.00 Mn
Sep 30, 2025 5.00 Mn
Jun 30, 2025 4.00 Mn
Mar 31, 2025 8.00 Mn
Dec 31, 2024 23.00 Mn
Sep 30, 2024 4.00 Mn
Jun 30, 2024 5.00 Mn
Mar 31, 2024 6.00 Mn
Jun 30, 2023 4.00 Mn
Mar 31, 2023 4.00 Mn
Jun 30, 2022 3.00 Mn
Mar 31, 2022 5.00 Mn
Dec 31, 2021 19.00 Mn
Sep 30, 2021 1.00 Mn
Jun 30, 2021 4.00 Mn
Mar 31, 2021 5.00 Mn
Dec 31, 2020 19.00 Mn
Sep 30, 2020 2.00 Mn
API Access

Astrazeneca Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=AZN&period=max&api_key=YOUR_API_KEY